Effect of age and gender on pharmacokinetics of atorvastatin in humans

Journal of Clinical Pharmacology

Volumn 36, Issue 3, 1996, Pages 242-246

  Gibson, Donald M ^a   Bron, Nicola J ^a   Richens, Alan ^a   Hounslow, Neil J ^a   Sedman, Allen J ^a   Whitfield, Lloyd R ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN;

ADULT; AGE; AGED; AREA UNDER THE CURVE; ARTICLE; CHOLESTEROL SYNTHESIS; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG METABOLISM; ENZYME INHIBITION; FEMALE; GENDER; HUMAN; HUMAN EXPERIMENT; LIVER METABOLISM; MALE; SCINTILLATION SPECTROMETRY;

EID: 0030005053     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1552-4604.1996.tb04194.x     Document Type: Article

References (21)

1. Bocan TMA, Ferguson E, McNally W, Uhlendorf PD, Mueller SB, DeHart P, et al: Hepatic and nonhepatic sterol synthesis and tissue distribution following administration of a liver selective HMG-CoA reductase inhibitor, CI-981: comparison with selected HMG-CoA reductase inhibitors. Biochim Biophys Acta 1992;1123: 133-144.
2. Whitfield LR, Cilla DD Jr, Posvar EL, Sedman AJ, Gibson DM: Single- and multiple-dose pharmacokinetics of CI-981, a potent HMG-CoA reductase inhibitor (abstract). Pharm Res 1993; 10(suppl):S-340.
3. Cilla DD Jr, Radulovic LL, Whitfield LR, Posvar EL, Sedman AJ: Safety, tolerance and pharmacokinetic profiles following single doses of CI-981, a potent HMG-CoA reductase inhibitor (abstract). Pharm Res 1993;10(suppl):S-332.
4. Duggan DE, Chen I-W, Bayne WF, Halpin RA, Duncan CA, Schwartz MS, et al: The physiological disposition of lovastatin. Drug Metab Dispos 1989;17.166-173.
5. Vickers S, Duncan C, Chen I, Rosegay A, Duggan D: Metabolic disposition studies on simvastatin, a cholesterol lowering prodrug. Drug Metab Dispos 1990;18:135-145.
6. Quion JAV, Jones PH: Clinical pharmacokinetics of pravastatin. Clin Pharmacokinet 1994;27:94-103.
7. McKenny JM: Lovastatin: a new cholesterol-lowering agent. Clin Pharmacokinet 1988;7:21-36.
8. Mauro VF: Clinical pharmacokinetics and practical applications of simvastatin. Clin Pharmacokinet 1993;24:195-202.
9. Lipid Research Clinics Program: The lipid research clinics coronary primary prevention trial results. I. Reduction in the incidence of coronary heart disease. JAMA 1984;257:3233-3240.
10. Lerner DJ, Kannel WB: Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J 1986;111:383-390.
11. Lintott CJ, Scott RS: HMG-CoA reductase inhibitor use in the aged: a review of clinical experience. Drugs Aging 1992;2:518-529.
12. Greenblatt DJ, Sellers EM, Shader RI: Drug disposition in old age. N Engl J Med 1982;306:1081-1088.
13. Wilson K: Sex-related differences in drug disposition in man. Clin Pharmacokinet 1984;9:189-202.
14. Shum YY, Huang H, Walter G, Black AE, Sekerke CS, Homan R, et al: Development and validation of an enzyme inhibition assay for quantitation of CI-981 in human plasma (abstract). Pharm Res 1993;10(suppl):S-415.
15. Gibaldi M, Perrier D: Pharmacokinetics. New York: Marcel Dekker, 1980.
16. Bolton S: Pharmaceutical Statistics: Practical and Clinical Applications. New York: Marcel Dekker, 1990.
17. SAS Institute, Inc.: Statistics. In, SAS User's Guide, Version 5. Cary, NC: SAS Institute, 1985.
18. Pan HY, Waclawski AP, Funke PT, Whigan D: Pharmacokinetics of pravastatin in elderly versus young men and women. Ann Pharmacother 1993;27:1029-1033.
19. Cheng H, Rogers JD, Sweany AE, Dobrinska MR, Stein EA, Tate AC, et al: Influence of age and gender on the plasma profiles of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitory activity following multiple doses of lovastatin and simvastatin. Pharm Res 1992;9:1629-1633.
20. Woodhouse KW, Wynne HA: Age-related changes in liver and hepatic blood flow: the influence on drug metabolism in the elderly. Clin Pharmacokinet 1988;15:287-294.
21. Uchiyama N, Kagami Y, Saitoh Y, Ohtawa M: Male-specific metabolism of simvastatin by rat liver microsomes. Chem Pharm Bull (Tokyo) 1991;39:236-238.